• Avaí Bio attended the Second Annual Klotho Conference in Miami on Sept. 18-19.
• Walter H. Günzburg presented a 20-minute update on sustained α-Klotho delivery using Austrianova’s Cell-in-a-Box encapsulated-cell technology.
• Work is being developed through Klothonova, a 50/50 joint venture formed in 2025 between Avaí Bio and Austrianova.
• Program remains preclinical; the partners reported a completed GMP master cell bank for α-Klotho-producing genetically modified cells.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avai Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609240845PRIMZONEFULLFEED9833113) on September 24, 2026, and is solely responsible for the information contained therein.